Glucocorticoid use in rheumatoid arthritis

Area of Science:

• Rheumatology
• Endocrinology
• Bone Metabolism

Background:

• Glucocorticoids have been used for over 50 years to treat rheumatoid arthritis (RA).
• While short-term efficacy is clear, emerging evidence suggests a disease-modifying role for glucocorticoids in RA.
• Despite their benefits, glucocorticoid therapy is associated with significant adverse events, notably bone complications.

Purpose of the Study:

• To review the long-term data on glucocorticoid use in rheumatoid arthritis.
• To highlight the risk of glucocorticoid-induced osteoporosis.
• To emphasize the importance of identifying high-risk patients and implementing preventive strategies.

Main Methods:

• Literature review of studies on glucocorticoid efficacy and adverse events in RA.
• Analysis of data regarding the incidence and risk factors for glucocorticoid-induced osteoporosis.
• Discussion of current preventive measures for bone complications.

Main Results:

• Glucocorticoids demonstrate significant efficacy in managing rheumatoid arthritis symptoms.
• Long-term use of glucocorticoids is linked to a high risk of osteoporosis.
• Osteoporosis is a predictable and serious complication in both chronic and acute glucocorticoid users.

Conclusions:

• Glucocorticoids remain a critical treatment for rheumatoid arthritis, with growing evidence of disease-modifying properties.
• The risk of glucocorticoid-induced osteoporosis necessitates careful patient monitoring and proactive management.
• Early identification of patients susceptible to bone complications and timely intervention are crucial to mitigate adverse outcomes.